Fair Housing Initiatives Program - Education and Outreach Initiative
Congress in 1988 established the Fair Housing Initiatives Program (FHIP) with a purpose of providing funding to entities to work alongside HUD to "prevent or eliminate discriminatory housing practices" 42 USC § 3616a(a). FHIP provides funds to eligible organizations through competitive grants. under several initiatives.The overarching purpose of the FHIP Education and Outreach Initiative (EOI) is to educate the public, housing providers and other stakeholders about their rights and obligations under provisions of fair housing laws, through the development, implementation, carrying out and coordinating or education and outreach programs. 42 USC § 3616a(d)(1); 24 CFR 125.301(a).The National Media Campaign component (EOI-NMC) is "designed to provide a centralized, coordinated effort for the development and dissemination of fair housing media products." 42 USC § 3616a(d)(1). A portion of NMC funds are specifically meant to increase participation in the annual national fair housing month. Under a cooperative agreement, HUD will exercise the right to approve, and have substantial involvement in, all proposed deliverables, as well as the Work Plan or Statement of Work (SOW).The General Component (EOI-GC) is designed to carry out projects programs that prevent or eliminate discriminatory housing practices by establishing or supporting regional, local, and community- based education and outreach activities, events, and programs. For grants and cooperative agreements, HUD will conduct monitoring reviews, request quarterly reports, and approve all proposed deliverables as documented in the applicant's Work Plan or SOW. Most EOI funds are awarded under grant agreements. However, national funds are awarded under cooperative agreements managed by Headquarters since the awards have a nationwide impact and therefore require more complex and frequent oversight as well as Departmental approval of deliverables.
OFH-2600-DC-021A
Award Ceiling
$2.5M
Closes
Nov 2, 2026
6d left
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, modeling, and validation with available large-scale datasets.
PAR-25-255
Award Ceiling
—
Closes
Nov 5, 2026
9d left
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
<p>Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.</p>
PAR-25-095
Award Ceiling
$350K
Closes
Nov 6, 2026
10d left
Impact Aid Discretionary Construction Grant Program - 84.041C
The Employment and Training Administration at the U.S. Department of Labor (DOL) is soliciting applications in support of the administration of the Impact Aid Discretionary Construction Grant Program on behalf of the U.S. Department of Education (ED). The Impact Aid Discretionary Construction Grant Program provides grants to eligible Impact Aid Local Educational Agencies (LEAs) to assist in addressing their school facility emergency and modernization needs. This competition is limited to emergency grants that meet the absolute priority and other requirements in this notice. The competition uses existing statutory authority and appropriated funds to address urgent school facility needs in federally connected communities while promoting responsible stewardship of taxpayer dollars.
DOL-OESE-34832
Award Ceiling
$8.0M
Closes
Nov 10, 2026
14d left
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
<p>Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.</p>
PAR-25-096
Award Ceiling
$200K
Closes
Nov 17, 2026
21d left
Institute of Education Sciences (IES): National Center on Education Research (NCER): From Seedlings to Scale, Assistance Listing Number (ALN) 84.305J
<p>Through the From Seedlings to Scale (S2S) Grants program, IES will invest in innovative ideas within an identified focus area through three phases of increasing funding and duration to support ideas as they grow from seedlings to scalable solutions. Projects will incorporate high-quality research, robust solution development, and attention to sustainability and scaling throughout all phases. </p><p> </p><p>For the FY 2027 S2S program, IES invites applications for Phase One projects under the Coordinating Systems to Translate Evidence into Policy and Practice (C-STEP) focus area. C-STEP seeks to develop and rigorously test innovative AI- and technology-enabled solutions that help education systems intentionally integrate evidence-based products, processes, and policies to improve outcomes for prekindergarten through grade 12 students. Proposed solutions should reflect a deep understanding of the systems in which they operate and enable education leaders to align resources, anticipate impacts, and overcome implementation barriers, thereby strengthening the connection between research, policy, and practice.</p><p><br></p><p>Assistance Listing Number (ALN): 84.305J</p>
ED-GRANTS-101526-001
Award Ceiling
$500K
Closes
Dec 11, 2026
45d left
Institute of Education Sciences (IES): National Center for Special Education Research (NCSER): Transformative Research in Special Education, Assistance Listing Number (ALN) 84.324T
<p>Through the Transformative Research in Special Education Grants program, IES seeks to support research and development of transformative solutions to seemingly intractable problems and challenges in special education. Transformative projects enact bold and innovative thinking, involve interdisciplinary collaboration, are inherently risky, and use high-quality research approaches to create high-reward, scalable solutions with the potential to lead to dramatic improvements for students with or at risk for disabilities. </p><p> </p><p>In FY 2027, the Transformative Research in Special Education Grants program will focus on Phase 1 grants to research and develop transformative solutions to dramatically improve preservice teacher education systems so they can better attract, train, and retain preK-12 general and special education teachers who are prepared to provide high-quality instruction and substantially improve outcomes for students with or at risk for disabilities. </p><p><br></p><p>Assistance Listing Number (ALN): 84.324T</p>
ED-GRANTS-101526-002
Award Ceiling
$3.8M
Closes
Dec 11, 2026
45d left
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.
PAR-25-081
Award Ceiling
$500K
Closes
Jan 7, 2027
72d left
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.
PAR-25-079
Award Ceiling
$500K
Closes
Jan 7, 2027
72d left
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increase the risk of some, while decreasing the risk of other obesity related cancers.
PAR-25-070
Award Ceiling
—
Closes
Jan 7, 2027
72d left
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
<p>The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole.This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.</p>
PAR-24-214
Award Ceiling
$375K
Closes
Jan 7, 2027
72d left
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
<p>The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. </p><p>Interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings, and referral to accessible care. Projects are encouraged to leverage collaborations with community partners and service providers. Interventions should address barriers and facilitators at two or more of the following levels: patient, clinician, healthcare setting, and neighborhood/community. Specific research interests of participating NIH ICs are detailed within.</p>
PAR-25-098
Award Ceiling
—
Closes
Jan 7, 2027
72d left
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
<p>Not available</p>
PAR-25-379
Award Ceiling
—
Closes
Jan 7, 2027
72d left
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
<p>The purpose of the Worta McCaskill-Stevens K12 funding opportunity is to support institutional career development awards designed to prepare newly trained clinicians who have made a commitment to independent research careers in community oncology or cancer prevention, and to facilitate their transition to more advanced support mechanisms or independent research funding (e.g., K08, R03, R21, R01).The NOFO will allow the appointment of Scholars proposing to serve as the lead investigator of an independent community-based clinical trial; or proposing a separate ancillary study to an existing prevention, screening or control clinical trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of a wide variety of communities in cancer clinical research, as part of their research and career development.</p>
PAR-24-153
Award Ceiling
—
Closes
Feb 18, 2027
114d left
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
<p>The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.</p>
RFA-DA-25-060
Award Ceiling
$1.5M
Closes
Mar 5, 2027
129d left
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
<p>The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.</p>
RFA-DA-25-024
Award Ceiling
—
Closes
Mar 6, 2027
130d left
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
<p>The purpose of this initiative is to advance the science of minority health and health disparities by supporting research on family health and well-being and resilience. The NIMHD Research Framework recognizes family health, family well-being, and family resilience as critically important areas of research to decrease disparities and promote equity.</p>
PAR-25-317
Award Ceiling
—
Closes
Mar 6, 2027
130d left
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
<p>This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this NOFO, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.</p>
PAR-24-329
Award Ceiling
—
Closes
Mar 16, 2027
140d left
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Courses for Skills Development
RFA-OD-25-003
Award Ceiling
$200K
Closes
Apr 9, 2027
164d left
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA
PA-24-179
Award Ceiling
—
Closes
May 7, 2027
192d left